Jessica Lynn – WHAT NEXT

Author: Jessica Lynn

Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

April 26, 2024 • Views: 4

Alecensa Now FDA-Approved for Early-Stage ALK+ NSCLC

Bladder Cancer • Urothelial Carcinoma

April 25, 2024 • Views: 7

ICYMI: Opdivo Combination Approved for Metastatic Urothelial Carcinoma

Prostate cancer

April 22, 2024 • Views: 8

ICYMI: Lynparza Approved in Scotland for Metastatic Castration-Resistant Prostate Cancer

Multiple Myeloma

April 15, 2024 • Views: 127

First Patient Dosed in TCR-NK Cell Therapy Trial for Multiple Myeloma

Colorectal Cancer

April 9, 2024 • Views: 16

ICYMI: First Patient Dosed in Phase 2 Study for Metastatic RAS-Mutated Colorectal Cancer

Bacteria found in colorectal cancer

Colorectal Cancer

April 4, 2024 • Views: 17

Colorectal Cancer Tumors with Fusobacterium Nucleatum C2 Have Worse Outcomes

Acute myeloid leukemia

April 3, 2024 • Views: 16

ICYMI: Ocifisertib Earns Orphan Drug Designation for Acute Myeloid Leukemia

Chronic Myelomonocytic Leukemia

March 18, 2024 • Views: 24

IO-202 for Chronic Myelomonocytic Leukemia (CMML) Earns Orphan Drug Designation

Polycythemia vera

Polycythemia Vera

March 12, 2024 • Views: 17

DISC-3405 for Polycythemia Vera Earns Orphan Drug Designation

Pancreatic Cancer

March 11, 2024 • Views: 36

STUDY: Targeted Mass Spectrometry Could Identify Pancreatic Cancer Through Blood Test

We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.

Let's Work Together

Site Map

Sign up for our weekly summary of articles and conversation.

↑

Close

Rare Black History: A Childhood Home of Rare Disease… August 31, 2023
Study of the Week: New Method for Personalizing Head… April 17, 2023
Mantle Cell Lymphoma: Not Yet Curable, But This… March 1, 2023
New Investigative Therapy Could Drastically Minimize… March 1, 2023
Researchers Develop Deeper Understanding of Acral… May 16, 2023